RespireRx Pharmaceuticals Inc. to Present at 10th Annual Biotech Showcase™ 2018
08. Januar 2018 08:45 ET
|
RespireRX Pharmaceuticals Inc.
CEO to Review completed Phase IIB dronabinol trial for the treatment of Obstructive Sleep Apnea (OSA) and Provide Pipeline update Glen Rock, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- RespireRx...